Form 4: Prestige Consumer Healthcare Inc.: Senior VP Operations, Jeffrey Zerillo, Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., reports the acquisition of 1,837 restricted stock units.
Summary
- On May 5, 2025, Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., acquired 1,837 restricted stock units.
- These restricted stock units vest in three installments: 612 shares on May 5, 2026, 612 shares on May 5, 2027, and 613 shares on May 5, 2028.
- Following this transaction, Zerillo beneficially owns 43,402 shares of Prestige Consumer Healthcare Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns management interests with shareholders.
Positives
- The acquisition of restricted stock units aligns the executive's interests with the long-term performance of the company.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the restricted stock units suggests a multi-year commitment from the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates an equity-based compensation component for a senior executive, which is a common practice in the industry.
Comparison to Industry Standards
- Equity compensation is a standard practice across the consumer healthcare industry to align management interests with shareholder value.
- Companies like Church & Dwight, Reckitt Benckiser, and P&G also utilize restricted stock units as part of their executive compensation packages.
- The vesting schedule and amount of shares granted are typical for executives at similar levels within comparable companies.
Stakeholder Impact
- The acquisition of restricted stock units by a senior executive can positively influence shareholder confidence by aligning management's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| August 7, 2018 | Date of power of attorney on file with the Commission. |
| May 5, 2025 | Transaction date: Acquisition of restricted stock units. |
| May 5, 2026 | First vesting date: 612 shares. |
| May 5, 2027 | Second vesting date: 612 shares. |
| May 5, 2028 | Third vesting date: 613 shares. |
| May 7, 2025 | Date of signature. |
Keywords
Prestige Consumer Healthcare Inc., Jeffrey Zerillo, restricted stock units, beneficial ownership, Form 4, SEC, PBH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.